Prevalence and risk factors for fragility fracture in systemic mastocytosis-Reference-Cited by-同舟云学术

Prevalence and risk factors for fragility fracture in systemic mastocytosis

Published:2017-12 Issue: Volume:105 Page:219-225
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Degboé Yannick,Eischen Marine,Nigon Delphine,Apoil Pol-André,Mailhol Claire,Tournier Emilie,Laurent Camille,Hanssens Katia,Hermine Olivier,Paul Carle,Laroche Michel,Bulai-Livideanu Cristina

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal;Valent;J. Allergy Clin. Immunol.,2012

2. Diagnostic criteria and classification of mastocytosis: a consensus proposal;Valent;Leuk. Res.,2001

3. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients;Escribano;J. Allergy Clin. Immunol.,2009

4. Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis;Rossini;Osteoporos. Int.,2016

5. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis;van der Veer;Allergy,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mastocytose als oorzaak van osteoporotische fracturen: casusbespreking en literatuurstudie;Tijdschrift voor Geneeskunde;2023-07-17

2. Assessment of Bone Microarchitecture in Patients with Systemic Mastocytosis and its Association with Clinical and Biochemical Parameters of the Disease;Calcified Tissue International;2023-06-09

3. Comprehensive mastocytosis data analysis from a single center;BMC Cancer;2023-01-24

4. New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy;Annual Review of Pathology: Mechanisms of Disease;2023-01-24

5. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice;The Journal of Allergy and Clinical Immunology: In Practice;2022-08